Integrative Multi-Omics and Experimental Analyses Identify TAPBP as a Key Mediator Linking Genetic Susceptibility to Melanocyte Dysfunction in Vitiligo
Clinical, Cosmetic and Investigational Dermatology · 2026-01 · Volume 19 · 1-10
DOI: 10.2147/ccid.s577486 ↗At a glance
Journal article in Clinical, Cosmetic and Investigational Dermatology, 2026-01. Written by Jinlong Shi and 4 co-authors. Institution: Department of Dermatology, Zhengzhou People's Hospital, Zhengzhou, Henan, People's Republic of China. 42 references. The full text is freely available (open access, CC BY-NC 3.0).
Abstract (original language)
Background
Vitiligo is an autoimmune depigmenting disorder characterized by selective melanocyte loss; however, the specific molecular bridges between genetic risk variants and melanocyte-intrinsic immune vulnerability remain largely unexplored.
Objective
To elucidate the molecular link between genetic susceptibility and melanocyte injury in vitiligo by integrating multi-omics data.
Methods
We integrated large-scale genome-wide association data (FinnGen R12, n=466,064), expression quantitative trait loci (eQTLgen, n=31,684), and single-cell transcriptomic profiles to identify genes mediating vitiligo susceptibility.
Results
Cross-omic analysis identified TAPBP as a top candidate, which is significantly upregulated in lesional melanocytes and core to the antigen-processing network. Functional validation in human melanocytes demonstrated that TAPBP overexpression significantly increased HLA class I expression, suppressed cell proliferation, and induced apoptosis. Transcription factor analysis further identified STAT2 as a key upstream regulator, linking interferon signaling to aberrant antigen presentation.
Conclusion
These findings suggest that the STAT2-TAPBP axis enhances melanocyte immunogenicity and vulnerability to cytotoxic attack. Our study provides a novel mechanistic link between genetic variation and immune-mediated destruction, positioning TAPBP as a potential biomarker and a target for precision immunotherapy in vitiligo.
Subjects
Author keywords
Authors and institutions
- Department of Dermatology, Zhengzhou People's Hospital, Zhengzhou, Henan, People's Republic of China.
- Department of Laboratory, Women and Children's Hospital Affiliated to Qingdao University, Qingdao, Shandong, People's Republic of China.
- Department of Dermatology, Suining Central Hospital, Suining, Sichuan, People's Republic of China.
ORCID profiles: Yuan Hu
Cite
APA
Shi, J., Guo, M., Fu, L., He, J., & Hu, Y. (2026). Integrative Multi-Omics and Experimental Analyses Identify TAPBP as a Key Mediator Linking Genetic Susceptibility to Melanocyte Dysfunction in Vitiligo. Clinical, Cosmetic and Investigational Dermatology, Volume 19, 1-10. https://doi.org/10.2147/ccid.s577486
Vancouver
Shi J, Guo M, Fu L, He J, Hu Y. Integrative Multi-Omics and Experimental Analyses Identify TAPBP as a Key Mediator Linking Genetic Susceptibility to Melanocyte Dysfunction in Vitiligo. Clinical, Cosmetic and Investigational Dermatology. 2026;Volume 19:1-10. doi:10.2147/ccid.s577486
BibTeX
@article{Shi2026,
author = {Shi, Jinlong and Guo, Mingzhen and Fu, Liying and He, Jiangman and Hu, Yuan},
title = {Integrative Multi-Omics and Experimental Analyses Identify TAPBP as a Key Mediator Linking Genetic Susceptibility to Melanocyte Dysfunction in Vitiligo},
journal = {Clinical, Cosmetic and Investigational Dermatology},
year = {2026},
volume = {Volume 19},
pages = {1--10},
doi = {10.2147/ccid.s577486}
}
EUVIMED